DIN 02261847 — SANDOZ-CARBAMAZEPINE CR 400 MG
SANDOZ-CARBAMAZEPINE CR is a tablet (extended-release) of Carbamazepine marketed by SANDOZ CANADA INCORPORATED. The full Carbamazepine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02261847
- Brand name
- SANDOZ-CARBAMAZEPINE CR
- Active ingredient
- Carbamazepine
- Strength
- 400 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Anticonvulsant (iminostilbene derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Carbamazepine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00402699 | APO-CARBAMAZEPINE | 200 MG | TABLET | APOTEX INC | DORMANT |
| 00504742 | MAZEPINE | 200 MG | TABLET | BIOMED PHARMA | DORMANT |
| 02541238 | MINT-CARBAMAZEPINE | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02261839 | SANDOZ-CARBAMAZEPINE CR | 200 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02367394 | TARO-CARBAMAZEPINE | 100 MG | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED |
| 02244403 | TARO-CARBAMAZEPINE CHEWABLE TABLETS | 100 MG | TABLET (CHEWABLE) | TARO PHARMACEUTICALS INC | MARKETED |
| 02244404 | TARO-CARBAMAZEPINE CHEWABLE TABLETS | 200 MG | TABLET (CHEWABLE) | TARO PHARMACEUTICALS INC | MARKETED |
| 00010405 | TEGRETOL | 200 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 00773611 | TEGRETOL CR | 200 MG | TABLET (EXTENDED-RELEASE) | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 00755583 | TEGRETOL CR | 400 MG | TABLET (EXTENDED-RELEASE) | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02194333 | TEGRETOL SUSPENSION | 100 MG | SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 00782718 | TEVA-CARBAMAZEPINE | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED |